Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
RealMed Launches New Website
Align Technology to Announce Second Quarter Fiscal 2009 Results on July 23, 2009
TeamHealth Recognized by National Quality Agency
Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks
Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.